Version 1
: Received: 31 July 2020 / Approved: 2 August 2020 / Online: 2 August 2020 (12:07:34 CEST)
Version 2
: Received: 10 February 2021 / Approved: 10 February 2021 / Online: 10 February 2021 (15:04:19 CET)
How to cite:
Jolly, M.K.; Murphy, R.J.; Bhatia, S.; Whitfield, H.J.; Davis, M.J.; Thompson, E.W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints2020, 2020080023. https://doi.org/10.20944/preprints202008.0023.v1
Jolly, M.K.; Murphy, R.J.; Bhatia, S.; Whitfield, H.J.; Davis, M.J.; Thompson, E.W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints 2020, 2020080023. https://doi.org/10.20944/preprints202008.0023.v1
Jolly, M.K.; Murphy, R.J.; Bhatia, S.; Whitfield, H.J.; Davis, M.J.; Thompson, E.W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints2020, 2020080023. https://doi.org/10.20944/preprints202008.0023.v1
APA Style
Jolly, M.K., Murphy, R.J., Bhatia, S., Whitfield, H.J., Davis, M.J., & Thompson, E.W. (2020). Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints. https://doi.org/10.20944/preprints202008.0023.v1
Chicago/Turabian Style
Jolly, M.K., Melissa J. Davis and Erik W. Thompson. 2020 "Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications" Preprints. https://doi.org/10.20944/preprints202008.0023.v1
Abstract
The epithelial-mesenchymal (E/M) hybrid state has emerged as an important mediator of the elements of cancer progression facilitated by epithelial mesenchymal plasticity (EMP). We review here the evidence for the presence and prognostic potential of E/M hybrid state in carcinoma, modelling predictions and validations studies to demonstrate stabilised E/M hybrid intermediates along the spectrum of EMP, and computational approaches for characterising and quantifying EMP phenotypes, with particular attention to the emerging realm of single-cell approaches through RNA sequencing and protein-based approaches.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.